Insider Trading Flip‑Flop: SI‑BONE CEO Dunn Buys 20K Shares After Heavy Sell‑Off, Signaling Confidence Amid Market Volatility

Insider Activity at SI‑BONE Inc. – A Closer Look at Jeffrey W. Dunn’s Recent Deal

The latest Form 4 shows that on August 3, 2026, Jeffrey W. Dunn purchased 20,000 shares of SI‑BONE common stock at an average price of $4.68. The buy comes after a period of aggressive selling by Dunn, who has off‑loaded roughly 70,000 shares over the past six months at prices ranging from $13.15 to $21.28. The most recent sale on June 5, 2026, saw him unload 3,575 shares at $15.25, cutting his stake from 20,114 to 16,057 shares. The current purchase, however, restores his position to 36,057 shares and brings his holdings close to the 36‑k mark that he held before the series of sales.

What Does This Mean for Investors?

Dunn’s oscillation between selling and buying is consistent with a “trading plan” strategy. His August 3 buy was executed under a 10b5‑1 plan dated May 7, 2025, allowing him to lock in a purchase price before any potential market-moving information becomes public. This indicates that management believes the stock is fairly valued and that the company’s recent earnings—$18.44 closing price, 15 % revenue growth, and a narrower loss—justify a long‑term stake. For investors, the move suggests that insiders are still willing to accumulate, which can be a positive signal. However, the broader insider sell‑side activity (e.g., Pisecky, Maheshwari, and Francis each sold significant blocks in July) tempers enthusiasm, hinting at a need for caution until the company’s guidance and cash‑flow profile solidify.

Dunn’s Historical Trading Patterns

Historically, Dunn has been a frequent seller. He began the year with a 20,000‑share sale at $21.28 on January 8, 2026, then sold 337 shares in early May and 337 shares in February at prices above $16. The most notable block sale was 18,759 shares on December 8, 2025, at $19.33. These sales were largely at or above the 12‑month high of $21.89, suggesting he has been capitalizing on strong market prices. Yet he has also made several purchases, most recently 1,241 shares at $4.32 in December 2025 and 1,241 shares at $4.32 in 2025 (the same day), indicating that he is comfortable buying back into the company when the price dips below the 52‑week low of $11.48. This pattern portrays Dunn as a “price‑reactive” insider: he sells during peaks and buys during troughs, aiming to average down over time.

Implications for SI‑BONE’s Future

SI‑BONE’s recent results and guidance revisions have already pushed the share price down 2.17 % for the week, but the company remains within its 52‑week high/low range. The company’s earnings report highlighted a 15 % revenue lift, but its P/E remains negative at -46.1, reflecting ongoing net losses. Insider buying such as Dunn’s suggests confidence that the company will return to profitability as its minimally invasive solutions gain market share. For investors, the best takeaway is to monitor the next earnings call and watch for any further insider trades—particularly if a larger block sale is announced, which could signal a shift in sentiment.

Bottom Line

Jeffrey W. Dunn’s recent buy is a textbook example of disciplined, rule‑based insider trading that balances risk and reward. While insider selling has been aggressive, the consistent accumulation points to a long‑term belief in SI‑BONE’s product pipeline and market positioning. Investors should weigh this insider sentiment against the company’s negative earnings and the broader sell‑side activity, remaining vigilant for any sudden changes in insider ownership that could precede a market move.